EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program

Philip Zeitler, Rodolfo J. Galindo, Melanie J. Davies, Brandon Bergman, Vivian T. Thieu, Claudia Nicolay, Sheryl Allen, Clare J. Lee, Karsten Milek

Diabetologie und Stoffwechsel · 01.04.2024 · 19 (S 01 S 01) · S75-S76

DOI: 10.1055/s-0044-1785385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologie und Stoffwechsel, erschienen am 01.04.2024. Verfasst von Philip Zeitler und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Does treatment with tirzepatide (TZP) improve glycemic control, body weight (BW) and cardiometabolic markers in participants with early-onset T2D?

Method

In this post-hoc analysis changes from baseline in mean HbA1c, BW, waist circumference (WC), and cardiometabolic markers including lipids, and blood pressure (BP) were compared in participants with early-onset (N=873, 20.5%) vs later-onset type 2 diabetes (T2D) (N=3394, 79.5%) at Week 40 (SURPASS-1, -2, -5) or Week 52 (SURPASS-3).

Results

No differential treatment effect was observed for participants with early- vs later-onset T2D. TZP treatment led to similar improvements in HbA1c and BW in both subgroups at Week 40/52 for all TZP doses. Furthermore, TZP (all doses) improved WC, lipids (triglycerides and HDL) and systolic BP similarly between the two groups.

Conclusion

TZP treatment led to similar improvements in HbA1c, BW and cardiometabolic markers (WC, lipids, systolic BP) in participants regardless of having early-onset or later-onset T2D. Publication History Article published online: 18 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Zeitler, P., Galindo, R. J., Davies, M. J., Bergman, B., Thieu, V. T., Nicolay, C., Allen, S., Lee, C. J., & Milek, K. (2024). Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program. Diabetologie und Stoffwechsel, 19(S 01 S 01), S75-S76. https://doi.org/10.1055/s-0044-1785385

Vancouver

Zeitler P, Galindo RJ, Davies MJ, Bergman B, Thieu VT, Nicolay C, et al. Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program. Diabetologie und Stoffwechsel. 2024;19(S 01 S 01):S75-S76. doi:10.1055/s-0044-1785385

BibTeX
@article{Zeitler2024,
  author = {Zeitler, Philip and Galindo, Rodolfo J. and Davies, Melanie J. and Bergman, Brandon and Thieu, Vivian T. and Nicolay, Claudia and Allen, Sheryl and Lee, Clare J. and Milek, Karsten},
  title = {Efficacy of Tirzepatide in People with Early-Onset T2D in the SURPASS Program},
  journal = {Diabetologie und Stoffwechsel},
  year = {2024},
  volume = {19},
  number = {S 01 S 01},
  pages = {S75--S76},
  doi = {10.1055/s-0044-1785385}
}
Kostenlos starten →